New developments in the diagnosis and treatment of thyroid cancer. - Wikidata - awgldk - TriplyDB

New developments in the diagnosis and treatment of thyroid cancer.

New developments in the diagnosis and treatment of thyroid cancer.

http://www.wikidata.org/entity/Q37238757

about

Calcification of thyroid nodules increases shear-wave speed (SWS) measurement: using multiple calcification-specific SWS cutoff values outperforms a single uniform cutoff value in diagnosing malignant thyroid nodules.Efficacy of Superselective Neck Dissection in Detecting Metastasis in Patients with cN0 Papillary Thyroid Carcinoma at High Risk of Lateral Neck Metastasis.Analysis of radioiodine therapy and prognostic factors of differentiated thyroid cancer patients with pulmonary metastasis: An 8-year retrospective study.MicroRNA-mediated networks underlie immune response regulation in papillary thyroid carcinoma.Treating medullary thyroid carcinoma in a tertiary center. Current trends and review of the literature.Novel thyroidectomy difficulty scale correlates with operative times Lymph node metastases do not impact survival in follicular variant papillary thyroid cancer.All thyroid ultrasound evaluations are not equal: sonographers specialized in thyroid cancer correctly label clinical N0 disease in well differentiated thyroid cancer.Expression profiles of pivotal microRNAs and targets in thyroid papillary carcinoma: an analysis of The Cancer Genome Atlas.TMP21 modulates cell growth in papillary thyroid cancer cells by inducing autophagy through activation of the AMPK/mTOR pathway.Hurthle Cell Lesion: Controversies, Challenges, and Debates.MicroRNA Expression Profiles in Papillary Thyroid Carcinoma, Benign Thyroid Nodules and Healthy Controls.Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis.An evaluation of the diagnostic efficacy of fine needle aspiration biopsy in patients operated for a thyroid nodular goiter.A panel of four genes accurately differentiates benign from malignant thyroid nodules.Markedly elevated thyroglobulin levels in the preoperative thyroidectomy patient correlates with metastatic burden.Association between height and thyroid cancer risk: a meta-analysis of prospective cohort studies.Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy.Effect of Hashimoto thyroiditis on low-dose radioactive-iodine remnant ablation.Identification of potential biomarkers and drugs for papillary thyroid cancer based on gene expression profile analysis.Association between radioiodine treatment for thyroid cancer and risk of stroke.Next-generation sequencing for endocrine cancers: Recent advances and challenges.Notch3 expression correlates with thyroid cancer differentiation, induces apoptosis, and predicts disease prognosis.Quality indicators for thyroid cancer surgery: current perspective.Genetic Association of XRCC1 Gene rs1799782, rs25487 and rs25489 Polymorphisms with Risk of Thyroid Cancer: a Systematic Review and Meta-Analysis Clinicopathological characteristics of thyroid cancer in the federal state of Salzburg.HABP2 p.G534E variant in patients with family history of thyroid and breast cancer.Intraoperative radiotherapy for the treatment of thyroid cancer: a pilot study.Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings Identification of novel long non-coding RNA biomarkers for prognosis prediction of papillary thyroid cancer.The rare intracellular RET mutation p.S891A in a Chinese Han family with familial medullary thyroid carcinoma.Therapeutic response and long-term outcome of differentiated thyroid cancer with pulmonary metastases treated by radioiodine therapy.Tumor-suppressive function of UNC5D in papillary thyroid cancer.LncRNA CRNDE promotes cell proliferation, invasion and migration by competitively binding miR-384 in papillary thyroid cancer.Telomerase reverse transcriptase mutations are independent predictor of disease-free survival in Middle Eastern papillary thyroid cancer.Upregulated LAMB3 increases proliferation and metastasis in thyroid cancer.Novel iodinated gold nanoclusters for precise diagnosis of thyroid cancer.Parity and Risk of Thyroid Cancer: a Population-Based Study in Lithuania.A novel tumor suppressor gene NCOA5 is correlated with progression in papillary thyroid carcinoma.Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer.

P2860

Q30360500-843AF273-0026-4E04-A03C-19AAFD01F3DD Q33662263-357AFA06-617F-49A4-BB79-02B7233A3EE3 Q33672603-433B4E06-9ADC-4146-B271-2A972EB88783 Q34259271-868C68F9-24A9-4A5F-A2A4-D3A4779B0FDB Q34361439-2E525391-3E0F-4510-931E-9F20598B4E81 Q34610464-0AA8775E-EB97-43D6-99DD-396EAE1ABCE7 Q34765342-6E4EC474-57D6-4E34-B0F6-FE36C442F2CA Q35088281-911F8AC9-5E5C-4045-9F1B-0BA94E8462F2 Q36015168-A28433FE-5E43-47FB-852C-60337B86E22F Q36261540-9853A2BD-B3AD-40E6-BC0E-2A2796EEE7EF Q36844951-97EBFF67-4C96-4258-8D1C-955EBCE4DEE5 Q36882561-F2464ABA-7E50-493B-B3DB-75C065ED3C10 Q37005057-3629BA04-A3AA-455E-B9B8-C112EF970C50 Q37283505-D05F8E7E-7304-483B-A4AB-A651FAC0E5A2 Q37374678-3FDF7DB6-3034-4000-B645-6AA3B0B25046 Q37428853-98DA2D10-C4A6-46E9-AB08-CED25F5FE843 Q38360698-D533E076-FC29-4EC3-8153-64CFFC0FF067 Q38371740-047A4536-279D-48B2-A531-7ECACBF05C40 Q38426754-A6B30DAD-54D6-45C8-8FBF-6BD6B479E706 Q38441339-65DA7E19-C90A-459B-9311-F6B805B59FBC Q38620857-74AC027F-A143-4706-945F-82CDCD9BCC8E Q38689095-975D8439-95BE-47C0-ABC2-3128D7FCF815 Q38730437-1D1912AB-0ECF-477D-A329-5224D4777C48 Q38827992-6C4DB78E-99F8-48D4-B6B2-43BBF565C021 Q38939868-0EC95B13-2D90-4122-8767-4BEBD189776D Q40206178-F315CAD5-E769-4B66-B134-F0B95819D56B Q40245949-B6A122A4-C5AB-4E47-AB5F-206D2D793D58 Q40477756-1EF30A00-B1DB-45BB-8CC6-80940BE179DD Q40498719-FDA6F9BD-5F2D-4488-B2DA-EFE1042BCA8F Q41233998-5F791FD8-C4BE-487F-A9B3-3F395573D475 Q42459261-D20A889E-FF3A-4CE0-8376-FFA47CF0FD35 Q46205309-C70706A7-C0CD-4253-9613-3AF3CC477A35 Q47135233-2D18EF2D-FA31-4C6A-A38E-58D9B238F0B4 Q47155951-82AA4870-20E7-422F-B375-505DA81921BF Q47266315-C9D42D42-25B5-4839-8158-9AE8220F6688 Q47298385-9C34FA5E-0D61-4F8D-A1D4-E30BAEF13A11 Q48314076-1ED9D6EB-6522-4C2F-8763-FA5F66C48C14 Q48336001-3D99F457-036B-4BCD-93EA-72D6D4B1EF9F Q49387480-BD8F167D-320F-485E-A887-5D8F869EF4B2 Q50067658-67C1E086-3CC3-4C86-90B9-A7918F44E17D

P2860

New developments in the diagnosis and treatment of thyroid cancer.

http://www.wikidata.org/entity/Q37238757

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

New developments in the diagnosis and treatment of thyroid cancer.

@en

New developments in the diagnosis and treatment of thyroid cancer.

@nl

type

label

New developments in the diagnosis and treatment of thyroid cancer.

@en

New developments in the diagnosis and treatment of thyroid cancer.

@nl

prefLabel

New developments in the diagnosis and treatment of thyroid cancer.

@en

New developments in the diagnosis and treatment of thyroid cancer.

@nl

P1433

Q37238757-15397F9F-41FC-48C6-8286-BF020E3929BE

P1476

Q37238757-C9275693-5989-47E8-9BCB-CD9744665120

P2093

Q37238757-03BEE205-6CD0-440A-9EAC-3BF137D7D7E6

Q37238757-7E6907CB-E7CB-4C69-BF58-6C14C68D0B48

P2860

Q37238757-01AB8E5E-FB3F-4D65-BB32-214DCFBF6ACA

Q37238757-0238CC5A-4A8A-4E5E-A67D-6EF2718D80ED

Q37238757-03A445C6-78BD-47E4-B9D5-6E70B9F32281

Q37238757-05B0B515-2D26-4B3A-877D-A3F85067C70A

Q37238757-07570F90-5EDB-4680-A56F-6DA529C81BD1

Q37238757-0C602E22-FB4D-4986-A09A-30DAD1188720

Q37238757-0C729C5D-2938-42B4-87AC-03A073AA5572

Q37238757-0D5D91B7-480A-4F8B-8DA5-BAF97957CDD0

Q37238757-0E5BA4A8-5600-4A2E-9CA5-6166A1D2B377

Q37238757-1199CF84-1F1A-40C1-9F62-77566A73F189

P304

Q37238757-C348FB52-9253-4C82-8FC5-80002DDED22C

P31

Q37238757-C8A7EDB3-EA29-4BEE-8FC8-46566758CDF5

P356

Q37238757-2BAE9D4D-D876-4A28-84A8-137D78B67B45

P407

Q37238757-6F694E93-D35F-4EF7-BC0D-BBED3E1BFA04

P433

Q37238757-64BA117C-87B5-4410-AEDE-D89982489ACA

P478

Q37238757-ECC654E4-5727-4A69-A3CA-7F9943F08E99

P577

Q37238757-55F89665-78DF-4479-B81B-E8C67B776119

P5875

Q37238757-09975C26-87D9-421E-8695-0636A3952CE5

P698

Q37238757-F392DC8C-84D4-44D4-8D41-E942C857AB14

P921

Q37238757-91fe0c63-cbd2-4845-ad6c-4a8b99e5b505

P932

Q37238757-5274E0E1-1A5C-4C2C-96DA-E2D3C57958A8

P356

P1433

P1476

New developments in the diagnosis and treatment of thyroid cancer.

@en

P2093

David F Schneider

http://www.w3.org/2001/XMLSchema#string

Herbert Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer

RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study

Alteration of nucleosome structure as a mechanism of transcriptional regulation

Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level.

Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.

Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer.

Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients.

Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms.

P304

374-394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3322/CAAC.21195

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

241697868

http://www.w3.org/2001/XMLSchema#string

P698

23797834

http://www.w3.org/2001/XMLSchema#string

P921

P932

3800231

http://www.w3.org/2001/XMLSchema#string